-
PROVIDERS
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
LIFE SCIENCES
Introducing the Immune Profile Score
Explore the science behind the IPS test, a prognostic biomarker for patients on ICI therapy
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Original Webinar Date:
04/03/2024
Leveraging RNA sequencing to identify actionable biomarkers in NSCLC management
Join us in a dynamic discussion with Dr. Marc Matrana of Ochsner Health as he shares how RNA sequencing revealed new treatment options for his patient when DNA seq was unsuccessful identifying key, actionable biomarkers.
Speakers
Marc Matrana, MD, FACP, MS
System Director of Precision Medicine, Ochsner Health
Gary I. Grad, MD
Senior Medical Oncologist, Tempus
Ezra Cohen, MD FRCPSC, FASCO
Chief Medical Officer of Oncology, Tempus
System Director of Precision Medicine, Ochsner Health
Gary I. Grad, MD
Senior Medical Oncologist, Tempus
Ezra Cohen, MD FRCPSC, FASCO
Chief Medical Officer of Oncology, Tempus
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more